<dd id="rw0xn"></dd>
If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.
IAEA Human Health Series No. 10
English STI/PUB/1446 | 978-92-0-102710-8
94 pages | 1 figure | € 35.00 | Date published: 2010This publication has been written for students and professionals in radiation oncology and cancer control programmes. It serves as a source of information on treatment decisions with regard to hepatocellular carcinoma (HCC), or liver cancer. Radiotherapy plays a major role in the treatment of HCC, which is one of the most common causes of cancer death globally. However, to date there have been no uniform recommendations, and the use of radiotherapy is limited by pre-existing liver disease. The present publication reports the results of an assessment of the role of radiotherapy within the entire framework of HCC management. It may guide the appropriate use of limited resources towards the most appropriate indications, and help in differentiating the approaches used for cure or palliation of HCC.
More Information on reusing IAEA copyright material.
Orders and requests for information may also be addressed to:
Publishing Section
International Atomic Energy Agency
Vienna International Centre
PO Box 100, A-1400 Vienna,
Austria
Tel.: +43 1 2600 22529, +43 1 2600 22530
Email: sales.publications@iaea.org
<dd id="rw0xn"></dd>
